-
r37980778c78--a381a5ef34360a74bbc64a1f80292396
Comparison of participant characteristics for 6 g/d of d-aspartic acid (DAA) and placebo (PLA), presented as mean±SD. -
r37980778c78--46122dda03dde29ba5718f787bd88413
Performance of dose diary adherence assessment compared to dye stain assay. -
Patients characteristics at baseline.
Abbreviations: EDSS = Expanded Disability Scale Status; GEL = gadolinium enhancing lesions; ml = milliliter; MSFC = Multiple sclerosis functional composite; MSSS =... -
r37980778c78--69852499f04f07eed57e089f86b64699
BackgroundKetorolac has been associated with a lower risk of recurrence in retrospective studies, especially in patients with positive inflammatory markers. It is still unknown... -
Subject demographics.
All values represent either number of subjects or the mean±SEM. aRepresents years of education completed. Completion of GED scored as 12 years. The groups were significantly... -
r37980778c78--d338943cd7e353c5b14d4b47a7f6953e
Efficacy analyses for primary outcomes (ADAS-Cog 12 and CDR-sb), and the key secondary outcome (DAD). -
Nitroglycerin for treatment of retained placenta: A randomised, placebo-contr...
BackgroundRetained placenta following vaginal delivery is a major cause of postpartum haemorrhage. Currently, the only effective treatments for a retained placenta are the... -
Characteristics of included studies.
RCT: Randomised controlled trial. GS: Gilead Sciences. R: Roche. GSK: GlaxoSmithKline. NS: not stated. aCopies/mL converted to IU/mL by dividing by 5.bThe limit of detection of...